Body Dysmorphic DisorderNCT07036744
When The Mirror Is Wrong
A study testing MIND-over-MIRROR in people with Body Dysmorphic Disorder, run by University of Coimbra at 1 site in Portugal.
Trial summary
Body Dysmorphic Disorder (BDD) is a severe psychiatric condition characterized by persistent and intrusive preoccupations with perceived flaws in physical appearance, which are typically unnoticeable or appear minor to others. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Body Dysmorphic Disorder
- What is being tested?
- MIND-over-MIRROR
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 sitePortugal
- Study dates
- 29 Jan 2025to 9 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Aged between 18-65 years;
- Fluent Portuguese speakers;
- Over the cut-off score for the AAI (≥ 21) and the DCQ (≥ 9);
Who cannot join
- Pregnant;
- If medicated, not stabilized for at least 2 months
- Currently under other clinical psychology intervention;
- Current suicidal ideation;
Trial locations and contacts
1 site in 1 country.
Portugal1 site
CINEICC, Faculty of Psychology and Educational Sciences of the University of Coimbra
Coimbra, Coimbra District, 3000-115
About this study
Official title: When The Mirror Is Wrong: A Multi-Method Efficacy Study Of An Acceptance And Compassion-Based Group Intervention For Body Dysmorphia
Body Dysmorphic Disorder (BDD) is a severe psychiatric condition characterized by persistent and intrusive preoccupations with perceived flaws in physical appearance, which are typically unnoticeable or appear minor to others. BDD is associated with significant psychological distress, functional impairment, and reduced quality of life. Despite its prevalence and clinical severity, BDD remains frequently underdiagnosed and misdiagnosed. While Cognitive Behavioural Therapy (CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs) are currently considered standard treatments, emerging evidence suggests that third-wave psychotherapies, such as Acceptance and Commitment Therapy (ACT) and Compassion-Focused Interventions, may offer additional benefits.
This project aims to advance clinical care and scientific understanding of BDD by developing, implementing, and evaluating the preliminary efficacy of MIND-over-MIRROR-a novel group-based psychological intervention integrating ACT and compassion-based strategies for individuals exhibiting high levels of BDD symptomatology. The intervention consists of eight weekly sessions and one follow-up booster session, delivered in an online or hybrid format. A randomized feasibility study will be conducted to examine the intervention's acceptability, practicality, and preliminary clinical efficacy in adults aged 18 to 65 years. A multi-method assessment framework will be employed, with self-report measures collected at baseline, post-intervention, and 3-month follow-up. Additionally, participants from experimental and control groups will report on their weekly BDD symptomatology.
Participants in the intervention group who consent will also undergo computerized behavioural tasks and functional neuroimaging using functional near-infrared spectroscopy (fNIRS) to explore neural and cognitive correlates of treatment outcomes. Improvements are expected in core clinical outcomes, including BDD symptom severity, and it is hypothesized that changes in targeted psychological processes (e.g., self-compassion) will mediate these effects. This study will contribute novel and clinically relevant data regarding the feasibility and potential effectiveness of contextual behavioural therapies for BDD, with implications for both research and practice.
Read the detailed description
Body dysmorphic disorder (BDD) is a mental disorder described by an excessive preoccupation or obsession with a perceived defect or imperfection in one's physical appearance or body functionality that is either imperceptible or barely noticeable by others, as defined in the DSM-5. While general appearance concerns are normal, in BDD these concerns are taken to the extreme and have a great impact on the individual's daily functioning and quality of life. To match diagnostic criteria, individuals must also engage in repetitive activities/compulsions (e.g., mirror checking, skin plucking, and excessive grooming). BDD is also known to be associated with poor cognitive flexibility, impulsivity, and affective processing, showing specific neural correlates. BDD is a serious mental condition that can cause a great deal of distress. However, BDD has been globally overlooked and in Portugal, before the current project, screening or assessment measures had not yet been validated, and no specialised treatment options are currently available. BDD has long been underdiagnosed, since it usually involves a lack of insight, delusional beliefs, and is highly associated with shame and severe body-image problems, leading to symptom concealment.
In the last decades, pharmacological (Serotonin reuptake inhibitors) and Cognitive Behavioural Therapy (CBT) interventions have been successfully developed for the treatment of BDD, but with some limitations, specifically regarding relapse rates. More recently, 3rd generation interventions, such as Acceptance and Compassion-based therapy, have shown promising results in BDD-related disorders (e.g., obsessive-compulsive and eating disorders) as well as with non-clinical samples (e.g., body dissatisfaction).
Despite its promising results, the application of 3rd generation interventions in BDD is still limited. So far, only pilot studies have tested such interventions in adults with BDD symptomatology. In addition, several authors have recommended integrating compassion in the treatment of BDD, working to increase and specifically target shame and self-criticism, but no studies test the efficacy of compassion skills/strategies for BDD. Our hypothesis is that by targeting specific processes involved in the development of BDD, not only will symptoms improve, but overall quality of life and relapse rates will be positively impacted. This project aims to foster the assessment and treatment of BDD while contributing to the progress of 3rd generation interventions.
Thus, we will adapt, implement, and investigate the feasibility and preliminary efficacy of the online version of the Mind-over-Mirror, an innovative programme, which combines ACT and compassion-strategies, to be delivered in group format to individuals presenting BDD symptomatology. The programme's feasibility and preliminary efficacy will be evaluated within a parallel arm study comparing against a control condition/waiting list (individuals with BDD symptomatology who will not receive any type of psychological intervention during the course of the trial). A longitudinal and multi-methods outcomes approach will be implemented (primary outcome: BDD symptomatology; secondary outcomes: general mental health [depression] and ACT, and compassion-related psychological processes [self-compassion, body-specific and general psychological flexibility, and self-criticism]; other non-mandatory and exploratory outcomes: cognitive functioning [Emotional Stroop Task and Emotion Recognition Task] and associated brain activity changes using functional Near-Infrared Spectroscopy (fNIRS). All participants will be assessed at three moments (baseline, post-intervention and 3-month follow-up), as well as report weekly BDD symptomatology.
All procedures inherent to this project were approved by the Ethics Committee of the Faculty of Psychology and Educational Sciences, University of Coimbra. Informed consent from each participant was required prior to any data collection. The voluntary, confidential and pseudo-anonymised nature of the project was clearly explained, as well as the option to decline or withdraw at any moment without any negative consequence.
- Conditions
- Body Dysmorphic Disorder
- Being tested
- MIND-over-MIRROR
- Keywords
- Body Dysmorphic Disorder, Dysmorphic Concern, Acceptance and Commitment Therapy, Compassion, Psychological Flexibility, online group intervention
- Medical subject headings
- Body Dysmorphic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MIND-over-MIRRORBehavioural
An eight session (plus one follow-up booster session) on Acceptance and Commitment Therapy (ACT) with compassion developed specifically for BDD, in a group setting and applied remotely or in hybrid format.
| Study group | Role | What they receive |
|---|---|---|
| Control group | No intervention | Participants who present significant Body Dysmorphia Symptomatology, as assessed during the screening stage (n ≥ 8) not subjected to any clinical psychology intervention during the period of the current trial. Participants in this group will be assessed at baseline, post-intervention [immediately after session 8], and at the 3-month follow-up. They will also be asked to monitor their weekly symptoms through a short self-report assessment. |
| Intervention group | Experimental | Participants who present significant Body Dysmorphia Symptomatology, as assessed during the screening stage (n ≥ 8) subjected to an online manualized group psychological intervention - Mind-over-Mirror. This group will be assessed at baseline, post-intervention [immediately after session 8], and at the 3-month follow-up). They will also be asked to monitor their weekly symptoms through a short self-report assessment. Receives: Behavioral: MIND-over-MIRROR |
What is being measured
The primary outcome is the main question the study is designed to answer.
Appearance Anxiety Inventory
The Appearance Anxiety Inventory (AAI) is a brief 10 item self-report scale that assesses the cognitive and behavioral aspects of BDD in particular. This scale was specifically developed by the original authors as both an outcome and process measure, since it can track changes in these processes and behaviors during treatment. Besides its global score, the AAI includes three subscales: threat monitoring, camouflaging, and avoidance. Each item is scored on a 4-point scale ranging from not at all (0) to much more than most people (3). A score equal or above 21 is considered high risk body image anxiety and/or Body Dysmorphic Disorder.
Measured: Baseline, Weeks 1-8, 3-month follow-up
Dysmorphic Concern Questionnaire
The DCQ measures a person's degree of dysmorphic concern (i.e., the excessive preoccupation or concern with a perceived minor defect in one's physical appearance). This is a self-report measure with seven items, reporting on cognitive and behavioural aspects of dysmorphic concern. Each item is phrased with the question, "Have you ever…?" (e.g., "…been very concerned about some aspect of your physical appearance"). Each item is scored on a 4-point scale ranging from not at all (0) to much more than most people (3).
Measured: Baseline, Week 8, 3-month follow-up
Secondary outcomes (5)
Patient Health Questionnaire - 9
: The PHQ-9 is a brief nine-item questionnaire used to screen for the severity of depression in adults. It's based on DSM-IV criteria for major depressive disorder and assesses symptoms like depressed mood, loss of interest, fatigue, and suicidal ideation. All items are rated on a four-point scale from not at all (0) to nearly every day (3).
Measured: Baseline, Week 8, 3-month follow-up
Change in the Multidimensional Psychological Flexibility Inventory - 24
The MPFI-24 is a 24-item self-report scale for the assessment of psychological flexibility/inflexibility, comprised by 12 subscales, representing psychological flexibility (i.e., Acceptance, Present Moment Awareness, Self as Context, Defusion, Values, Committed Action) and psychological inflexibility (i.e., Experiential Avoidance, Lack of Contact with the Present Moment, Self as Content, Fusion, Lack of Contact with Values, Inaction). Items (e.g., "I opened myself to all of my feelings, the good and the bad") are answered on a 6-point Likert scale (ranging from 1 = 'never true' to 6 = 'always true') reporting to the previous 2 weeks. The scores of the 6 flexibility and 6 inflexibility subscales can be averaged to create a composite score representing global flexibility and inflexibility, respectively. Previous psychometric information indicates good to excellent internal consistency values.
Measured: Baseline, Week 8, 3-month follow-up
Self-compassion Scale
The SCS is a 26-item self-report questionnaire that measures six components of self-compassion: self-kindness (five items); self-judgment (five items); common humanity (four items); isolation (four items); mindfulness (four items); and overidentification (four items). Mean scores on the six subscales can be averaged (after reverse-coding negative items) to create an overall self-compassion score. Items are rated on a 5-point Likert scale ranging from 1 (almost never) to 5 (almost always), with good psychometric properties.
Measured: Baseline, Week 8, Follow-Up 3 Months
Psychological Flexibility for Body Image
The Psy-Flex-BI assesses body image-related psychological flexibility. Just like the Psy-Flex, a general psychological flexibility measure, it includes all six skills assumed to comprise psychological flexibility according to ACT theory. This scale is a 6-item measure (e.g., I can look at hindering thoughts regarding my physical appearance from a distance without letting them control me.), and items are rated on a scale from 5 ("very often") to 1 ("very rarely"). The scale was developed under the current project and has presented great psychometric properties.
Measured: Baseline, Week 8, Follow-Up 3 Months
Forms of Self-criticizing/Attacking and Self-reassuring Scale
The FSCRS is a 22-item self-report questionnaire that measures how participants typically think and react in situations where things go wrong. The scale comprises three subscales that assess two forms of self-criticism (Inadequate Self and Hated Self) and the ability to self-soothe (Reassured Self). Participants are asked to respond according to a 5-point Likert scale ranging from (0) Not at all like me to (4) Extremely like me. The scale has consistently showed good psychometric properties.
Measured: Baseline, Week 8, Follow-Up 3 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jun 2025
- Study start29 Jan 2025
- Primary completion9 Oct 2025
- Study completion9 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Body Dysmorphic DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This project will follow a longitudinal design. Adults presenting with BDD symptomatology will be randomly allocated to the Control Group (no intervention; n ≥ 8) or to the Intervention Group (Mind-over-Mirror group intervention; n ≥ 8).
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 18 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Coimbra
- Sponsor type
- University, hospital or other
- Collaborators
- Foundation for Science and Technology, Portugal
- Responsible party
- Principal investigator, Maria Coimbra, University of Coimbra
- Investigators
- Maria Coimbra, MSc, Principal investigator, CINEICC, Faculty of Psychology and Educational Sciences, University of CoimbraCláudia Ferreira, PhD, Principal investigator, CINEICC, Faculty of Psychology and Educational Sciences, University of CoimbraAna Ganho-Ávila, Ph.D., Principal investigator, CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07036744
- Sponsor's protocol ID
- 2022.12380.BD
- Other IDs
- 2022.12380.BD
- Status last verified
- Jun 2025
- First submitted
- 16 Jun 2025
- Last updated
- 6 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual Participant Data (IPD) will not be shared in order to protect participant confidentiality and in accordance with data protection regulations.
Study at a glance
From the registry record, last updated by the sponsor on 6 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- When The Mirror Is Wrong: A Multi-Method Efficacy Study Of An Acceptance And Compassion-Based Group Intervention For Body Dysmorphia
- ClinicalTrials.gov ID
- NCT07036744
- Acronym / sponsor ID
- 2022.12380.BD
- Conditions
- Body Dysmorphic Disorder
- Keywords
- Body Dysmorphic Disorder, Dysmorphic Concern, Acceptance and Commitment Therapy, Compassion, Psychological Flexibility, online group intervention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 18 participants (actual)
- Lead sponsor
- University of CoimbraUniversity, hospital or other
- Collaborators
- Foundation for Science and Technology, Portugal
- Study start
- 29 Jan 2025 (actual)
- Primary completion
- 9 Oct 2025 (actual)
- Study completion
- 9 Oct 2025 (actual)
- First posted
- 25 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Body Dysmorphic Disorder (BDD) is a severe psychiatric condition characterized by persistent and intrusive preoccupations with perceived flaws in physical appearance, which are typically unnoticeable or appear minor to others. BDD is associated with significant psychological distress, functional impairment, and reduced quality of life. Despite its prevalence and clinical severity, BDD remains frequently underdiagnosed and misdiagnosed. While Cognitive Behavioural Therapy (CBT) and Selective Serotonin Reuptake Inhibitors (SSRIs) are currently considered standard treatments, emerging evidence suggests that third-wave psychotherapies, such as Acceptance and Commitment Therapy (ACT) and Compassion-Focused Interventions, may offer additional benefits.
This project aims to advance clinical care and scientific understanding of BDD by developing, implementing, and evaluating the preliminary efficacy of MIND-over-MIRROR-a novel group-based psychological intervention integrating ACT and compassion-based strategies for individuals exhibiting high levels of BDD symptomatology. The intervention consists of eight weekly sessions and one follow-up booster session, delivered in an online or hybrid format. A randomized feasibility study will be conducted to examine the intervention's acceptability, practicality, and preliminary clinical efficacy in adults aged 18 to 65 years. A multi-method assessment framework will be employed, with self-report measures collected at baseline, post-intervention, and 3-month follow-up. Additionally, participants from experimental and control groups will report on their weekly BDD symptomatology.
Participants in the intervention group who consent will also undergo computerized behavioural tasks and functional neuroimaging using functional near-infrared spectroscopy (fNIRS) to explore neural and cognitive correlates of treatment outcomes. Improvements are expected in core clinical outcomes, including BDD symptom severity, and it is hypothesized that changes in targeted psychological processes (e.g., self-compassion) will mediate these effects. This study will contribute novel and clinically relevant data regarding the feasibility and potential effectiveness of contextual behavioural therapies for BDD, with implications for both research and practice.
Detailed description
Body dysmorphic disorder (BDD) is a mental disorder described by an excessive preoccupation or obsession with a perceived defect or imperfection in one's physical appearance or body functionality that is either imperceptible or barely noticeable by others, as defined in the DSM-5. While general appearance concerns are normal, in BDD these concerns are taken to the extreme and have a great impact on the individual's daily functioning and quality of life. To match diagnostic criteria, individuals must also engage in repetitive activities/compulsions (e.g., mirror checking, skin plucking, and excessive grooming). BDD is also known to be associated with poor cognitive flexibility, impulsivity, and affective processing, showing specific neural correlates. BDD is a serious mental condition that can cause a great deal of distress. However, BDD has been globally overlooked and in Portugal, before the current project, screening or assessment measures had not yet been validated, and no specialised treatment options are currently available. BDD has long been underdiagnosed, since it usually involves a lack of insight, delusional beliefs, and is highly associated with shame and severe body-image problems, leading to symptom concealment.
In the last decades, pharmacological (Serotonin reuptake inhibitors) and Cognitive Behavioural Therapy (CBT) interventions have been successfully developed for the treatment of BDD, but with some limitations, specifically regarding relapse rates. More recently, 3rd generation interventions, such as Acceptance and Compassion-based therapy, have shown promising results in BDD-related disorders (e.g., obsessive-compulsive and eating disorders) as well as with non-clinical samples (e.g., body dissatisfaction).
Despite its promising results, the application of 3rd generation interventions in BDD is still limited. So far, only pilot studies have tested such interventions in adults with BDD symptomatology. In addition, several authors have recommended integrating compassion in the treatment of BDD, working to increase and specifically target shame and self-criticism, but no studies test the efficacy of compassion skills/strategies for BDD. Our hypothesis is that by targeting specific processes involved in the development of BDD, not only will symptoms improve, but overall quality of life and relapse rates will be positively impacted. This project aims to foster the assessment and treatment of BDD while contributing to the progress of 3rd generation interventions.
Thus, we will adapt, implement, and investigate the feasibility and preliminary efficacy of the online version of the Mind-over-Mirror, an innovative programme, which combines ACT and compassion-strategies, to be delivered in group format to individuals presenting BDD symptomatology. The programme's feasibility and preliminary efficacy will be evaluated within a parallel arm study comparing against a control condition/waiting list (individuals with BDD symptomatology who will not receive any type of psychological intervention during the course of the trial). A longitudinal and multi-methods outcomes approach will be implemented (primary outcome: BDD symptomatology; secondary outcomes: general mental health [depression] and ACT, and compassion-related psychological processes [self-compassion, body-specific and general psychological flexibility, and self-criticism]; other non-mandatory and exploratory outcomes: cognitive functioning [Emotional Stroop Task and Emotion Recognition Task] and associated brain activity changes using functional Near-Infrared Spectroscopy (fNIRS). All participants will be assessed at three moments (baseline, post-intervention and 3-month follow-up), as well as report weekly BDD symptomatology.
All procedures inherent to this project were approved by the Ethics Committee of the Faculty of Psychology and Educational Sciences, University of Coimbra. Informed consent from each participant was required prior to any data collection. The voluntary, confidential and pseudo-anonymised nature of the project was clearly explained, as well as the option to decline or withdraw at any moment without any negative consequence.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- This project will follow a longitudinal design. Adults presenting with BDD symptomatology will be randomly allocated to the Control Group (no intervention; n ≥ 8) or to the Intervention Group (Mind-over-Mirror group intervention; n ≥ 8).
| Arm | Type | Receives |
|---|---|---|
| Control group | No intervention | –Participants who present significant Body Dysmorphia Symptomatology, as assessed during the screening stage (n ≥ 8) not subjected to any clinical psychology intervention during the period of the current trial. Participants in this group will be assessed at baseline, post-intervention [immediately after session 8], and at the 3-month follow-up. They will also be asked to monitor their weekly symptoms through a short self-report assessment. |
| Intervention group | Experimental | Behavioral: MIND-over-MIRRORParticipants who present significant Body Dysmorphia Symptomatology, as assessed during the screening stage (n ≥ 8) subjected to an online manualized group psychological intervention - Mind-over-Mirror. This group will be assessed at baseline, post-intervention [immediately after session 8], and at the 3-month follow-up). They will also be asked to monitor their weekly symptoms through a short self-report assessment. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Aged between 18-65 years;
- Fluent Portuguese speakers;
- Over the cut-off score for the AAI (≥ 21) and the DCQ (≥ 9);
Key exclusion criteria (4 listed)
- Pregnant;
- If medicated, not stabilized for at least 2 months
- Currently under other clinical psychology intervention;
- Current suicidal ideation;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MIND-over-MIRRORAn eight session (plus one follow-up booster session) on Acceptance and Commitment Therapy (ACT) with compassion developed specifically for BDD, in a group setting and applied remotely or in hybrid format. | Behavioural | Intervention group |
Primary outcome
Appearance Anxiety Inventory
Time frame: Baseline, Weeks 1-8, 3-month follow-up
The Appearance Anxiety Inventory (AAI) is a brief 10 item self-report scale that assesses the cognitive and behavioral aspects of BDD in particular. This scale was specifically developed by the original authors as both an outcome and process measure, since it can track changes in these processes and behaviors during treatment. Besides its global score, the AAI includes three subscales: threat monitoring, camouflaging, and avoidance. Each item is scored on a 4-point scale ranging from not at all (0) to much more than most people (3). A score equal or above 21 is considered high risk body image anxiety and/or Body Dysmorphic Disorder.
Dysmorphic Concern Questionnaire
Time frame: Baseline, Week 8, 3-month follow-up
The DCQ measures a person's degree of dysmorphic concern (i.e., the excessive preoccupation or concern with a perceived minor defect in one's physical appearance). This is a self-report measure with seven items, reporting on cognitive and behavioural aspects of dysmorphic concern. Each item is phrased with the question, "Have you ever…?" (e.g., "…been very concerned about some aspect of your physical appearance"). Each item is scored on a 4-point scale ranging from not at all (0) to much more than most people (3).
5 secondary outcomes
Patient Health Questionnaire - 9
Time frame: Baseline, Week 8, 3-month follow-up
Change in the Multidimensional Psychological Flexibility Inventory - 24
Time frame: Baseline, Week 8, 3-month follow-up
Self-compassion Scale
Time frame: Baseline, Week 8, Follow-Up 3 Months
Psychological Flexibility for Body Image
Time frame: Baseline, Week 8, Follow-Up 3 Months
Forms of Self-criticizing/Attacking and Self-reassuring Scale
Time frame: Baseline, Week 8, Follow-Up 3 Months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jul 2026.
- Individual participant dataSharing planned: No. Individual Participant Data (IPD) will not be shared in order to protect participant confidentiality and in accordance with data protection regulations.
Related trials for Body Dysmorphic Disorder
Active, not recruiting
Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns
Body Dysmorphic Disorder, Eating Disorders
Not yet recruiting
Overvaluation of Weight and Shape Intervention vs The Body Project
Body Image, Mental Health Outcomes
RecruitingPhase 2
Study of Dextromethorphan in OCD and Related Disorders
Obsessive-Compulsive Disorder, Illness Anxiety Disorder
Recruiting
Internet-delivered Cognitive-behaviour Therapy for Child and Adolescent Body Dysmorphic Disorder
Body Dysmorphic Disorders
Active, not recruitingObservational study
A Multi-Dimensional Model of cAre and transItion for Patients With cOmplex RAre Diseases
Rare Diseases, Mitochondrial Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Maria Coimbra, MSc principal investigator
CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra
Cláudia Ferreira, PhD principal investigator
CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra
Ana Ganho-Ávila, Ph.D. principal investigator
CINEICC, Faculty of Psychology and Educational Sciences, University of Coimbra
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing MIND-over-MIRROR in people with Body Dysmorphic Disorder, run by University of Coimbra at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Appearance Anxiety Inventory (time frame: Baseline, Weeks 1-8, 3-month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2026; AzTrials last refreshed its copy on 27 Oct 2026.